Safety Alerts
18th September 2023
18th September 2023
10th January 2023
Safety Updates and Recommendations for Healthcare Professionals on Anti-Tuberculosis Medication
29th July 2022
Inoserp TM Pan-Africa Snake Antivenom – (UNDER REVIEW)
29th July 2022
Snake Venom Anti-Serum – (UNDER REVIEW)
4-Mar-2022
Public Alert: Use of Diclofenac for Pain Management
4-Mar-2022
Safety Updates and Recommendations for Health Care Professionals
19-Aug-2020
Dexamethasone in Management of COVID-19 Patients
25-Mar-2020
Information on Hydroxychloroquine and Chloroquine for COVID-19 Patients
3-Oct-2019
Recall of Sure Lubricated Condoms Dotted
2-Oct-2019
Genotoxic contaminant, N-nitrosodimethylamine (N-NDMA) Impurity, in Ranitidine products
14-Mar-2019
14-Jan-2019
14-Jan-2019
Systemic and inhaled quinolone and fluoroquinolone antibiotics
12-Jul-2018
Recall of Valsartan containing products by Denk Pharma
11-Jul-2018
Recall of some specific brands of Gentamicin injection in the Kenyan market
11-Jul-2018
9-May-2018
28-May-2018
Important identified signals on Artemether Lumefantrine
8-May-2018
Important identified signals on Ceftriaxone
8-May-2018
26-Mar-2018
Recall of Gentamed injection batch no. 170603
8-Aug-2013
Suspension of registration of Hydroethyl Starch (HES) containing solutions
19-Mar-2010
Increased risk of myopathy with high doses of Simvastatin
23-Feb-2010
Prolongation of the QT interval due to Saquinavir boosted with Ritonavir
29-Jan-2010
Risk of non-cirrhotic portal hypertension in patients using Didanosine
21-Jul-2009
Public Alert on Herbal Contraceptive
21-Apr-2009
Updated recommendations concerning the interaction of Ceftriaxone and Calcium containing products